Cite
HARVARD Citation
Zhou, M. et al. (n.d.). Serum macrophage‐derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time. International journal of cancer. 137 (4), pp. 826-836. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhou, M. et al. (n.d.). Serum macrophage‐derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time. International journal of cancer. 137 (4), pp. 826-836. [Online].